ESTROGENS (oestrogens or œstrogens)
·
A hormone that
comprises a group of compounds; it is the main sex hormone in women and is
essential to the menstrual cycle.
·
Primarily secreted
by the ovary & produced by the cells of the developing graafian follicle.
·
Indications:
o
Menopause symptoms
(moderate to severe), “hot flashes”, prevention of postmenopausal osteoporosis, ovarian
failure ,breast cancer ,advanced cancer of the prostate, osteoporosis, abnormal
bleeding of the uterus, vaginal irritation, female castration, Tumers syndrome, birth control
·
Contraindications:
o
Known or suspected
pregnancy, breastfeeding mothers, undiagnosed abnormal genital bleeding,
patients with breast cancer, endometrial hyperplasia, endometrial cancer,active
deep vein thrombosis, pulmonary embolism,liver dysfunction or disease,
hypersensitivity to estrogens
Example:
|
chlorotrianisene
(TACE Capsules®)
|
dienesterol ( DV Vaginal Cream®)
|
estradiol (Estrace, Climara, Estraderm, Fempatch,
Vivelle®)
|
estradiol cypionate ( Depo-Estradiol)
|
estradial valerate ( Delestrogen)
|
estrogens, conjugated ( Cenestin Tablets ®,Premarin
Tablets/Vaginal Cream®)
|
estrogens, esterified (Estratab®)
|
estrone ( Aquest, Estragyn 5®)
|
estropipate ( Ogen
Ortho-Est®)
|
ethinyl estradiol ( Estinyl® )
|
Side Effects:
·
Enlargement or
tenderness of breasts (both sexes)
·
Hair loss
·
Loss of appetite
·
Weight changes,
retention of water
·
Nausea, vomiting
·
Dizziness
·
Abdominal cramps
·
Feeling of
bloatedness
·
Swelling of the
ankles & legs
·
Skin rash,
irritation
·
Change in sexual
desire
Nursing Considerations:
For
Oral Estrogen
ü Take with food or immediately after eating to decrease
nausea.
ü If miss dose, take as soon as remembered, unless it is
just before next dose.
ü Do not take double doses
Transdermal
Estrogen
ü Wash hands before & after applying patch.
ü Apply to intact, hairless site on abdomen.
ü Press disc to other site for 10 seconds & check to
make sure edges are secure.
ü Avoid application to waistline or breasts as clothing
can loosen the disc.
ü Rotate sites & do not reuse site for 7 days.
ü Disc may be reapplied if it falls off.
Vaginal
ü Stay in a recumbent position at least 30 minutes after
inserting.
ü Do not use
tampons, but sanitary napkins may be used to protect clothing.
ü If dose is missed, do not use missed dose, wait until
next regularly scheduled dose.
ü Use provided applicator to insert vaginal cream or
tablet.
ü Wash applicator with mild soap & water after each
use.
Vaginal
Ring
ü To insert, press ring into oval & insert into upper
third of the vagina.
ü No discomfort should be felt, if it occurs ring may not
be inserted high enough & can be gently pushed into vagina.
ü Left in place for 90 days.
ü If expelled, rinse with lukewarm water & reinsert.
ü Ring can be expelled by pulling out with a finger.
ü Take note ring does not interfere with sexual
intercourse.
PROGESTINS
·
A synthetic
progestogen that has some biological activity similar to progesterone.
·
Progesterone &
progestins produce secretion changes in the endometrium for preparation of
implantation and nourishment of the embryo.
·
Indications:
o
Amenorrhea,
dysmenorrhea, endometriosis, infertility, threatened abortion, contraception,
premenstrual syndrome (PMS), adjunct or palliative treatment for carcinomas
·
Contraindications:
o
Known or suspected
pregnancy, lactation, unexplained vaginal bleeding, breast cancer, active
thrombophlebitis, pulmonary emboli, cardiac disease, cerebrovascular, disease,
liver disease, hypersensitivity, anti-seizure & antibiotics
medications(rifampin/rifampicine)
Example:
|
hydroxyprogesterone (
Hylutin®)
|
levonorgestrel ( Norplant®)
|
medroxyprogesterone
(Cycrin,Provera®)
|
medroxyprogesterone (
Depo-Provera®)
|
medroxyprogesterone &
conjugated estrogens (Premphase, Prempro®)
|
megestrol (Megace®)
|
progesterone ( Prometrium®)
|
progesterone (Gesterol,
Crinone, Progestasert®)
|
Side Effects:
·
Headache
·
Nausea, vomiting
·
Diarrhea/Constipation
·
Changes in the
menstrual flow
·
Breast tenderness
·
Chloasma
·
Rashes
·
|
·
Amenorrhea
·
Osteoporosis
Nursing Considerations: (ESTROGENS & PROGESTINS)
ü Read drug instructions carefully & contact health
care provider for questions.
ü Follow doctor’s orders regarding the
ü Instruct patient to take as prescribed & not to
change the dose or stop the medicine unless advised to do so by the health care
provider.
ü Perform self-breast exams monthly & report lumps to
health care provider.
ü Use sunscreen & protective clothing to prevent
photosensitivity reactions.
ü Inform other heath care providers before surgery or any
other treatment.
ü Diabetics should report increased glucose levels to
health care provider as dosage adjustments to oral hypoglycemic or insulin may
be necessary.
ü Report immediately any of the following to the health
care provider: headache, blurred vision, chest pain, swelling, tenderness in
extremities, shortness of breath, depression, weight gain, jaundice and if
bleeding occurs estrogen is withheld.
For Oral Progestin
ü Take a tablet every day at the same time each day.
Taking it for 3 hours late is the same as missing a dose which can affect the
effectivity of the drug.
Subdermal
(Norplant)
ü Six implants are inserted under the skin of the upper
arm by a health care professional, which take about 15 minutes. No pain should
be felt during the insertion process. Keep the gauze wrap on for 24 hours after
the insertion, and then sterile strips of tape should be left over the area for
3 days.
ü No heavy lifting for 24 hours.
ü Full protection from pregnancy begins within 24 hours,
if the insertion is done within 7 days of the beginning of menstrual period.
ü Protection last for 5 years.
Parenteral/
Intramuscular
ü Given every 3 months by heath care professionals.
ü Full protection from pregnancy begins as soon an the
first injection within the first 5 days of menstrual period or within 5 days
after delivering a baby if breastfeeding is not done, & 6 weeks
from delivery date for breastfeeding.
ORAL CONTRACEPTIVES
·
Inhibit ovulation
by increasing serum estrogen & progestin, which inhibit the secretion of
the follicle stimulating hormone (FSH) and lutenizing hormone (LH) from the
pituitary gland.
·
Indications:
o
Treatment of
hypermenorrhea, oral contraception, postcoital emergency contraception
·
Contraindications:
o
Pregnancy,
lactation, history of thromboembolic disorders, coronary disease,
cerebrovascular disease, liver tumors, undiagnosed vaginal bleeding, breast
cancer, estrogen-dependent neoplasms
Example:
|
desogestrel 0.15 mg (Desogen® )
|
ethinyl estradiol
30 mcg ( Yasmin®)
|
ethinyl estradiol 35 mcg (Demulen®
1/35)
|
ethinyl estradiol 20mcg (Mircette®)
|
ethinyl estradiol 35 mcg (Ortho Novum®)
|
ethinyl estradiol 40 mcg ( Triphasil® )
|
ethinyl estradiol 25mcg (Cyclessa®)
|
Side Effects:
·
Dizziness,
headache, lightheadedness
·
Edema
·
Abdominal pain
·
Nausea, vomiting
·
Diarrhea/constipation
·
Jaundice
·
Weight gain
·
Cramps
·
Amenorrhea
Adverse Effects:
·
Blood clots
·
Hypertension
Nursing Considerations:
·
Monitor BP &
report changes throughout the therapy.
·
Take exactly as
prescribed at the same time each day & in proper sequence. If pregnancy is
suspected stop taking & contact health care provider.
·
During the
beginning use of oral contraceptives, use an additional form of birth control
for the first cycle.
·
If one dose is
missed, take as soon as remembered. But then if 2 consecutive days are missed,
take 2 tablets a day for the next 2 days, continue with regular dosing schedule
and use an additional method of contraception for the rest of the cycle.
·
If 3 consecutive
days are missed, discontinue and use another form of contraception until menses
begins or pregnancy is ruled out.
·
Encourage patient
to perform monthly self-breast exam & notify physician if lumps are noted.
·
Stress the
importance of regular follow-up gynecological exams with health care provider,
including pap smears.
·
Report immediately
any of the following to the health care provider: headache, blurred vision,
chest pain, swelling, tenderness in extremities, shortness of breath, depression,
weight gain, jaundice and if bleeding occurs estrogen is withheld.
UTERINE STIMULANTS
·
Used to induce, or
augment labor, facilitate uterine contractions following a miscarriage, induce
abortion, or reduce hemorrhage following childbirth or abortion.
·
Oxytocics, ergot
alkaloids and prostaglandins stimulate uterine contractions.
·
Indications:
o
Oxytocics - induction of
labor, control postpartum or postabortion hemorrhage, intranasal: stimulation
of lactation
o
Ergot
Alkaloids – prevention &
treatment of postpartum or postabortion hemorrhage caused by uterine atony or
subinvolution
o
Prostaglandins – induce abortion from 12 to 20 weeks gestation,
management of nonmetastatic gestational trophoblastic disease, treatment of
incomplete abortion, fetal death within the uterus
·
Contraindications:
o
Spontaneous
threatened abortion , before the
delivery of the placenta it could cause placental entrapment,
hypersensitivity, pelvic
inflammatory disease, cervical
stenosis, uterine fibrosis
Example:
|
oxytocin (Pitocin, Syntocinon®)
|
dinoprostone ( Prepidil®
Gel, Prostine E®)
|
ergonovine (Ergotrate®)
|
methylergonovine (Methergine®)
|
carboprost thromethamine (Hemabate®)
|
Side Effects:
Oxytocics
·
Tachycardia,
hypertension, dysrhythmias
·
Seizures
·
Nause, vomiting
·
Uterine rupture
Ergot Alkaloids
·
Dizziness,
headache
·
Hypertension,
hypotension, dysrthythmias
·
Tinnitus
·
Nausea, vomiting
·
Cramps
·
Dyspnea
·
Diaphoresis
·
Pruritus
Prostaglandins
·
Hypertension,
hypotension
·
Headache,
drowsiness
·
Nausea, vomiting
·
Diarreha
·
Dyspnea
Nursing
Considerations:
Oxytocics
ü
Monitor maternal
vital signs frequently throughout the administration.
ü
Use fetal
monitoring & assess fetal heart rate continuously throughout the
administration.
ü
Assess character,
frequency, and duration of contractions.
ü
Patients receiving
parenteral oxytocin should be under medical supervision and should be
hospitalized.
ü
When administering
nasal spray to clear nasal passage, allow the patient to sit upright, hold
container upright, insert into nostril, and squeeze solution into nostril on
inspiration.
ü
Use an infusion
pump when administering IV and should be connected via a Y-site so that
oxyctocin can be disconnected while maintaining vein access.
Ergot Alkaloids
ü
Can be given through PO ,
IM, or IV(PO & IM are preferred, IV is use only for emergency).
ü
Monitor vital
signs, fundus (location, tone) , and vaginal drainage frequently throughout the
administration.
ü
Monitor calcium
levels; effectiveness is decreased with hypocalcemia.
ü
Avoid smoking as
nicotine increases the effects of ergot derivatives.
ü
Avoid double
dosing on missed dose. Omit and resume normal dosage schedule.
ü
Seek medical
attention if uterine relaxation is prolonged or if there are changes in vaginal
bleeding.
ü Report to the physician if the following symptoms are noted:
paresthesias, chest pain, and peripheral ischemia.
Prostaglandins
ü Assess the respiratory status of the patient and report
chest tightness, wheezing which could be a sign of anaphylaxis.
ü Remind the patient that fever may occur in 15 to 45
minutes after insertion of vaginal suppository but temperature returns to
normal 2 to 6 hours after discontinuation of therapy.
ü Monitor for nausea, vomiting, & diarrhea.
Administer antiemetic & antidiarrheal medications to provide comfort.
ü Monitor for hemorrhage & assess vaginal discharge.
UTERINE RELAXANTS (tocolytics)
·
Relax the smooth muscles of the uterus and prevent
contraction and labor induction which increases the chances of fetal survival.
·
Indications:
o
B2-
adrenergic Agonists, Nifedipine (Ca+ Channel Blockers),
COX inhibitors, Magnesium Sulfate –
inhibition of labor, reversal of uterotonic hyperstimulation, ease intrauterine
surgery, relief of dysmenorrheal
·
Contraindications:
o
Renal insufficiency, hypersensitivity, cardiovascular
disorders, pulmonary hypertension, hypokalemia
Example:
|
ritodrine ( Yutopar®)
|
terbutaline ( Bricanyl®)
Magnesium Sulfate
Terbutaline
|
Side Effects:
·
Hypotension
·
Blurred vision
·
Dizziness,
lightheadedness
·
Dry mouth
·
Chest pain or
tightness
·
Reflex tachycardia
·
Nausea, vomiting
·
Loss of appetite
·
Pulmonary edema
·
Cardio respiratory
arrest – Magnesium sulfate
Nursing Considerations:
ü
Monitor vital
signs especially respiratory rate, breath sounds, uterine contractions, and FHR
every 5 minutes when initiating the therapy, every 15-30 minutes when the patient
is stable.
ü
If administering
Mg SO4 frequently check deep tendon reflexes for signs of toxicity.
ü
Use an infusion
monitoring device during administration of the drug.
ü
Monitor potassium
& glucose levels.
ü
Stress the
importance of following treatment including bed rest.
ü
Notify health care
provider if membranes rupture or if contractions resume, or if there is loss of
fetal activity.
ANDROGENS
·
Stimulate RNA
synthesis, resulting in increased protein production and in natural hormone in
males. Stimulate primary sex characteristics and maintenance of secondary sex
characteristics, may cause weight gain & increased musculature and
strength, and stimulate the production of red blood cells.
·
Indications:
o
Testosterone -
hypogonadism, delayed puberty, palliative treatment of androgen- responsive
breast cancer, endometriosis, fibrocystic, breast disease, prostate, hereditary
angioedema
o
Androgen
Inhibitors ( 5 Alpha- Reductase Inhibitors) – treatment of BPH, male androgenic
alopecia
o
Phosphodiesterase
Inhibitors – erectile dysfunction
·
Contraindications:
o
Pregnancy,
lactation, hypercalcemia, male patients with breast or prostate cancer, patients
with severe cardiac, renal, or hepatic disease, hypersensitivity, concurrent
use with organic nitrates & alpha blockers
Example:
|
testosterone (
Testoderm®, Depo-Testosterone®, Androderm®)
|
testosterone cypionate
(Andro-Cyp®, Andronate®, depAndro®)
|
testosterone enanthate
( Andro®, Andropository®, Delatest®)
|
danazol ( Danocrine®)
|
Side Effects:
·
Headache,
depression
·
Insomnia
·
Nausea, vomiting
·
Deepening of the
voice
·
Gynecomastia
·
Menstrual
irregularities
·
Edema
Nursing
Considerations:
ü Monitor I & O, weight and report changes that
indicate fluid retention.
ü Monitor liver function studies, cholesterol, calcium
levels throughout the therapy.
ü Monitor for symptoms of virilism in women &
precocious puberty in men. Bone age determination should be done every 6 months
to assess rate of bone maturation.
ü Administer as prescribed, dose is tapered before being
discontinued & do not discontinue without consulting with the health care
provider.
ü Diabetic patients need to monitor blood sugar it may
cause hypoglycemia if insulin or oral hypoglycemic are taken.
Excellent blog very nice and unique information related to Reproductive System Drugs. Thanks for sharing this information.
ReplyDeleteBeclovent | Brethine
ReplyDeleteI was suffering from Parkinson's since 2016 & life had become disastrous for me,72 % of my body was covered by Tremors.After taking product from www.ultimateherbalclinic.com under supervision of Dr Ernest Albrecht, I started getting results within 3 weeks of their dosage .One day I got extremely sick, could not keep anything down, difficulty standing, restless sleep,I Started taking this remedies 2 times daily Morning and Evening, I am writing this to inform others that nothing was really working to help my PD other than this product.I went off my previous medications (with the doctor's knowledge) and started on their Parkinson's disease herbal formula.Treatment went very well and tremors are gone.